A. Foreno-Torres

A phase I trial of TRU-016, an anti-CD37 small modular immunopharmaceutical (SMIP) in relapsed and refractory CLL.

J. Byrd, I. Flinn, J. Flynn, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preliminary Phase II Results of SGN-30 (Anti-CD30 Monoclonal Antibody) in Patients with Cutaneous Anaplastic Large Cell Lymphoma (ALCL).

J. Zic, J. Kunishige, M. Duvic, 2005 .

A Phase 1 Trial of TRU-016, An Anti-CD37 Small Modular Immunopharmaceutical (SMIPTM) Protein in Relapsed and Refractory CLL: Early Promising Clinical Activity.

J. Byrd, I. Flinn, L. Andritsos, 2009 .